Spots Global Cancer Trial Database for gemcitabine hydrochloride for injection
Every month we try and update this database with for gemcitabine hydrochloride for injection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer | NCT06202261 | Metastatic Brea... Recurrent Breas... Advanced Malign... | TQB2930 for inj... Paclitaxel for ... TQB3616 capsule Fulvestrant inj... Capecitabine ta... Vinorelbine tar... Eribulin mesyla... gemcitabine hyd... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | NCT05193604 | Pancreatic Carc... | TQB2858 injecti... Anlotinib Hydro... Gemcitabine hyd... Paclitaxel for ... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | NCT05193604 | Pancreatic Carc... | TQB2858 injecti... Anlotinib Hydro... Gemcitabine hyd... Paclitaxel for ... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | NCT05193604 | Pancreatic Carc... | TQB2858 injecti... Anlotinib Hydro... Gemcitabine hyd... Paclitaxel for ... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Paclitaxel Polymeric Micelles for Injection Versus TPC on the Treatment of HER2-negative Metastatic Breast Cancer (MBC). | NCT06143553 | Metastatic Brea... | Paclitaxel Poly... Eribulin Mesila... Capecitabine Ta... Gemcitabine Hyd... Vinorelbine Tar... Paclitaxel (alb... | 18 Years - | Shanghai Yizhong Pharmaceutical Co., Ltd. | |
| A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | NCT05193604 | Pancreatic Carc... | TQB2858 injecti... Anlotinib Hydro... Gemcitabine hyd... Paclitaxel for ... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer | NCT05754853 | Advanced or Met... | MRG002 Docetaxel Injec... Paclitaxel Inje... Gemcitabine Hyd... Pemetrexed Diso... | 18 Years - 75 Years | Shanghai Miracogen Inc. | |
| A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer | NCT06202261 | Metastatic Brea... Recurrent Breas... Advanced Malign... | TQB2930 for inj... Paclitaxel for ... TQB3616 capsule Fulvestrant inj... Capecitabine ta... Vinorelbine tar... Eribulin mesyla... gemcitabine hyd... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects | NCT06079983 | Breast Cancer | JSKN003 Capecitabine ta... Gemcitabine hyd... Vinorelbine tar... Paclitaxel for ... Docetaxel injec... Eribulin mesyla... | 18 Years - | Jiangsu Alphamab Biopharmaceuticals Co., Ltd |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
